Results 71 to 80 of about 51,995 (213)

Pharmacoeconomics of Antibiotic Therapy

Canadian Journal of Infectious Diseases, 1994
During the past few years new drugs with greatly improved efficacy have become available to physicians and their patients. The higher purchase price of these new drugs is quite important and is quoted as a significant cause of the escalating cost of ...
Jacques Le Lorier
doaj   +1 more source

Differences in drug use between men and women: an Italian cross sectional study

BMC Women's Health, 2017
Background Drugs are the most important treatment option for most diseases, and the majority of medical consultations result in a prescription. Women and men receive different drug prescriptions and differ in therapeutic response to pharmacological ...
Daria Putignano, Dario Bruzzese, Valentina Orlando, Denise Fiorentino, Alessia Tettamanti, Enrica Menditto   +5 more
doaj   +1 more source

Tailoring an Implementation Strategy for Deprescribing as Part of a Comprehensive Geriatric Assessment (dCGA) in Long‐Term Care Facilities: A Roundtable Discussion

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 5, May 2026.
ABSTRACT Background Comprehensive geriatric assessments (CGAs), with deprescribing as an integral component, improve outcomes for older adults in long‐term care facilities (LTCFs). However, they remain underutilised in Croatia, partly due to systemic and cultural barriers, including limited recognition of pharmacists' roles.
Dora Belec, Kieran Dalton, Clara H. Heinrich, Maja Ortner Hadžiabdić, Maria D. Donovan   +4 more
wiley   +1 more source

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta

Neuropsychiatric Disease and Treatment, 2013
Florian Castrop, Bernhard Haslinger, Bernhard Hemmer, Dorothea Buck Department of Neurology, Technische Universität München, Munich, Germany Abstract: Multiple sclerosis (MS) is a common neurological disease with increasing incidence and ...
Castrop F, Haslinger B, Hemmer B, Buck D
doaj  

Decentralization and corruption - evidence across countries [PDF]

The relationship between decentralization of government activities and the extent of rent extraction by private parties is an important element in the recent debate on institutional design.
Fisman, Raymond, Gatti, Roberta
core  

Mapping the disease-specific LupusQoL to the SF-6D [PDF]

, 2015
Purpose To derive a mapping algorithm to predict SF-6D utility scores from the non-preference-based LupusQoL and test the performance of the developed algorithm on a separate independent validation data set.
AM Gray, C Browne, CA Marra, D Feeny, D Rowen, EM Pullenayegum, EM Tan, GR Barton, Ian Bruce, IN Bruce, J Brazier, J Brazier, J Brazier, J Cohen, J Ware Jr, Janice Abbott, JE Brazier, JE Brazier, JE Ware, JR Kirwan, K McElhone, K McElhone, K McELHONE, Kathleen McElhone, L Longworth, Lee-Suan Teh, M Hernández Alava, M Petri, M Sanchez, Mark Harrison, MC Hochberg, MF Drummond, MF Janssen, MJ Harrison, MJ Harrison, MR Gold, N Bansback, PM Fayers, PM Fayers, R Aggarwal, R Ara, R Meacock, Rachel Meacock, S Gabriel, S O’Neill, Sahena Haque, Y Ahmad, Y Yang, Z Touma   +48 more
core   +1 more source

Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3872-3882, May 2026.
Abstract Objective To comprehensively assess the cost‐utility of icodec, the first once‐weekly basal insulin, at 700 and 1050 U formulations compared with once‐daily basal insulin analogues in Chinese adults with type 2 diabetes within reimbursement context.
Xichen Tong, Chang Xing, Lei Zhang, Luying Zhang   +3 more
wiley   +1 more source

Costs, payments and incentives in family planning programs [PDF]

A variety of monetary policies regarding contraception exists around the world. These range from high user charges in some countries, to free contraceptives in many, to incentives and disincentives in others.
Isaacs, Stephen L., Ross, John A.
core  

Burden of Influenza and Cost‐Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India

Influenza and Other Respiratory Viruses, Volume 20, Issue 5, May 2026.
ABSTRACT Background In India, no publicly funded seasonal influenza immunization is ongoing, partly because cost‐effectiveness is yet to be established. We estimate the cost‐effectiveness and budgetary impact of introducing seasonal influenza vaccination among adults aged ≥ 60 years in India, a known high‐risk group. Methods Estimates of disease burden
Anand Krishnan, Aslesh Ottapura Prabhakaran, Kusum Shekhawat, Ismael R. Ortega‐Sanchez, Rakesh Kumar, Ritvik Amarchand, Prabu Rajkumar, Suman Kanungo, Sumit Dutt Bhardwaj, Giridara Gopal, Girish Kumar Chethrapilly Purushothaman, Varsha Potdar, Alok Kumar Chakrabarti, Radhika Gharpure, Avinash Choudekar, Kathryn E. Lafond, Lalit Dar, Siddhartha Saha, Kathrine R. Tan, Eduardo Azziz‐Baumgartner   +19 more
wiley   +1 more source

ANALYSIS OF THE COST OF THE DISEASE — PROBLEMS AND SOLUTIONS

Педиатрическая фармакология, 2011
The article discusses the estimation of the disease value, which includes direct, indirect and «intangible» costs. Advantages and disadvantages of different approaches to cost accounting, including the method of direct costs microcalculation compared ...
V.V. Omel'yanovskii, M.V. Avksent'eva, E.V. Derkach, N.D. Sveshnikova   +3 more
doaj   +2 more sources